For oral inhalation only. Shake the inhaler well before use. Exhale fully, place mouthpiece in mouth, press canister while inhaling slowly and deeply. Hold breath for 10 seconds. Exhale slowly. Rinse mouth with water after use to prevent oral candidiasis.

Fluticasone Propionate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity. It works by reducing inflammation in the airways, thereby decreasing bronchial hyperresponsiveness and the frequency and severity of asthma symptoms. It achieves this by inhibiting the release of inflammatory mediators and altering gene expression related to inflammatory proteins.

• •Acute bronchospasm or status asthmaticus (Fluticasone is not a rescue inhaler).
• •Primary treatment of status asthmaticus or other acute episodes of asthma or COPD where intensive measures are required.
• •Hypersensitivity to fluticasone propionate or any excipient.

Store below 30°C. Protect from direct sunlight, heat, and freezing. Do not puncture or incinerate the canister.

Acute overdose is unlikely to cause severe systemic effects. Chronic overdose may lead to signs of hypercorticism, including Cushing's syndrome, and adrenal suppression. Treatment is supportive; reduce dosage gradually.

Pregnancy Category C. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is unknown if fluticasone is excreted in human milk; use with caution in nursing mothers.